<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:mp ids='MP_0001845'>Inflammation</z:mp>, a process that involves neutrophils, lymphocytes, and monocytes, contributes to cerebral ischemic injury </plain></SENT>
<SENT sid="1" pm="."><plain>Blockade of neutrophil <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to endothelium improves outcome after experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In this study we sought to assess the contribution of lymphocytes and monocytes to ischemic brain injury </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Male Lewis rats underwent 3 hours of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> followed by 45 hours of reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>Two hours after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, one group of animals received an intraperitoneal injection of antibodies to the alpha(4) integrin (n=16); another group was injected with an isotype control antibody (n=11) </plain></SENT>
<SENT sid="5" pm="."><plain>Neurological examination, body temperature, and body weight were assessed at different time points after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Animals were killed 48 hours after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> for determination of <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and leukocyte counts </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: There were no significant differences in body temperature or weight at any time </plain></SENT>
<SENT sid="8" pm="."><plain>Neurological scores (deficits) were significantly less in animals treated with anti-alpha(4) antibodies at 24 (2.0+/-1.2 versus 3 </plain></SENT>
<SENT sid="9" pm="."><plain>0+/-0.4; P:=0.006) and 48 (2.0+/-1.2 versus 3.0+/-0.8; P:=0.011) hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Peripheral blood leukocyte counts were significantly higher in anti-alpha(4)-treated animals (6.8+/-2.2 x 10(9) versus 2.9+/-1.9 x 10(9); P:=0.001) and revealed a lymphocyte/monocyte predominance (86.0+/-16.2% versus 71.0+/-15.6%; P:=0.008) </plain></SENT>
<SENT sid="11" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume was significantly less in animals treated with antibodies to alpha(4) (120.1+/-51.21 versus 173.7+/-42.29 mm(3); P:=0.012) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: These data support a role for lymphocytes and monocytes in cerebral ischemic injury and show that blockade of alpha(4), even when instituted after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, can improve neurological outcome and decrease <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
</text></document>